Analytical methodology for developing nanomaterials designed for magnetically-guided delivery of platinum anticancer drugs.
Anticancer metal-based drugs
Delivery
Drug carriers
ICP-MS
Magnetic nanoparticles
Journal
Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R
Informations de publication
Date de publication:
01 Jun 2022
01 Jun 2022
Historique:
received:
24
01
2022
revised:
05
03
2022
accepted:
07
03
2022
pubmed:
15
3
2022
medline:
8
4
2022
entrez:
14
3
2022
Statut:
ppublish
Résumé
Metallodrug delivery using magnetic nanomaterials is emerging as a tool for the treatment of cancer because of its potential of enhanced and controlled delivery to a specific site within the body, reduced side effects, and protection of drugs from the extracellular environment. In this brief review, we discuss recent progress in the development of iron oxide nanoparticles loaded with platinum anticancer drugs due to applying modern analytical techniques. Such techniques may vary depending on what step of manufacture and assessment of magnetic nanocarriers is in question, i.e., drug loading, payload stability, magnetic properties, drug release or the efficiency against different cancer cell lines. While focusing on a wider implementation of advanced analytical methodologies, we also critically contemplate how they help create more potent magnetic nanoformulations, resolve the current challenges with the use of magnetic nanomaterials in smart metallodrug delivery and thus accelerate their translation to human treatments.
Identifiants
pubmed: 35287017
pii: S0039-9140(22)00167-9
doi: 10.1016/j.talanta.2022.123371
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Drug Carriers
0
Magnetite Nanoparticles
0
Platinum
49DFR088MY
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
123371Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.